Seres Therapeutics Inc.

NASDAQ: MCRB · Real-Time Price · USD
9.49
-0.21 (-2.16%)
At close: May 01, 2025, 3:59 PM
9.59
1.05%
After-hours: May 01, 2025, 06:32 PM EDT

Seres Therapeutics Revenue

Seres Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending December 31, 2024, Seres Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
103
Market Cap
82.73M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 0 -100.00%
Dec 31, 2023 126.33M +1672.24%
Dec 31, 2022 7.13M -95.08%
Dec 31, 2021 144.93M +336.33%
Dec 31, 2020 33.22M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.